연구동향 분석

Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma

박성혜 박철기 정희원 김태민 이세훈 김일한 김병혁 허대석 2014년

논문상세정보
인용/피인용
' Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • central nervous system
  • lymphoma
  • methotrexate
  • radiotherapy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,758 0

0.0%

' Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma' 의 참고문헌

  • Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas
    Wu HG J Korean Med Sci 14 : 565 ~ 570 [1999]
  • Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas
    Wu HG J Korean Med Sci 14 565-570 [1999]
  • Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma(PCL)
    Brada M Int J Radiat Oncol Biol Phys 40 : 1157 ~ 1162 [1998]
  • Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma(PCL)
    Brada M Int J Radiat Oncol Biol Phys 40 1157-1162 [1998]
  • Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma
    Soussain C J Clin Oncol 19 : 742 ~ 749 [2001]
  • Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma
    Soussain C J Clin Oncol 19 742-749 [2001]
  • Radiation Therapy Oncology Group Study 93-10. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10
    DeAngelis LM J Clin Oncol 20 : 4643 ~ 4648 [2002]
  • Radiation Therapy Oncology Group Study 93-10. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10
    DeAngelis LM J Clin Oncol 20 4643-4648 [2002]
  • Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature
    Murray K J Neurosurg 65 : 600 ~ 607 [1986]
  • Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature
    Murray K J Neurosurg 65 600-607 [1986]
  • Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy : results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study
    Montemurro M Ann Oncol 18 : 665 ~ 671 [2007]
  • Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy : results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study
    Montemurro M Ann Oncol 18 665-671 [2007]
  • Primary central nervous system lymphoma : results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy
    Pels H J Clin Oncol 21 : 4489 ~ 4495 [2003]
  • Primary central nervous system lymphoma : results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy
    Pels H J Clin Oncol 21 4489-4495 [2003]
  • Primary CNS lymphoma: a whole-brain disease?
    Lai R Neurology 59 : 1557 ~ 1562 [2002]
  • Primary CNS lymphoma: a whole-brain disease?
    Lai R Neurology 59 1557-1562 [2002]
  • Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas : initial report of radiation therapy oncology group protocol 88-06
    Schultz C J Clin Oncol 14 : 556 ~ 564 [1996]
  • Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas : initial report of radiation therapy oncology group protocol 88-06
    Schultz C J Clin Oncol 14 556-564 [1996]
  • Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma
    Deckert M Leukemia 25 : 1797 ~ 1807 [2011]
  • Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma
    Deckert M Leukemia 25 1797-1807 [2011]
  • Longterm outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation
    Gerstner ER Neurology 70 : 401 ~ 402 [2008]
  • Longterm outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation
    Gerstner ER Neurology 70 401-402 [2008]
  • Long-term follow-up of high-dose methotrexatebasedtherapy with and without whole brain irradiation fornewly diagnosed primary CNS lymphoma
    Gavrilovic IT J Clin Oncol 24 : 4570 ~ 4574 [2006]
  • Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma
    Gavrilovic IT J Clin Oncol 24 4570-4574 [2006]
  • Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation
    Shibamoto Y Cancer 97 : 128 ~ 133 [2003]
  • Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation
    Shibamoto Y Cancer 97 128-133 [2003]
  • Importance of radiotherapy in the outcome of patients with primary CNS lymphoma : an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments
    Bessell EM J Clin Oncol 20 : 231 ~ 236 [2002]
  • Importance of radiotherapy in the outcome of patients with primary CNS lymphoma : an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments
    Bessell EM J Clin Oncol 20 231-236 [2002]
  • High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma : European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962
    Poortmans PM J Clin Oncol 21 : 4483 ~ 4488 [2003]
  • High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma : European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962
    Poortmans PM J Clin Oncol 21 4483-4488 [2003]
  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma(G-PCNSL-SG-1) : a phase 3, randomised, non-inferiority trial
    Thiel E Lancet Oncol 11 : 1036 ~ 1047 [2010]
  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma(G-PCNSL-SG-1) : a phase 3, randomised, non-inferiority trial
    Thiel E Lancet Oncol 11 1036-1047 [2010]
  • High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years : a multicenter phase II study of the GOELAMS group
    Colombat P Bone Marrow Transplant 38 : 417 ~ 420 [2006]
  • High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years : a multicenter phase II study of the GOELAMS group
    Colombat P Bone Marrow Transplant 38 417-420 [2006]
  • Current management of primary central nervous system lymphoma
    Schultz CJ Int J Radiat Oncol Biol Phys 76 : 666 ~ 678 [2010]
  • Current management of primary central nervous system lymphoma
    Schultz CJ Int J Radiat Oncol Biol Phys 76 666-678 [2010]
  • Consolidation radiotherapy in primary central nervous system lymphomas : impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy
    Ferreri AJ Int J Radiat Oncol Biol Phys 80 : 169 ~ 175 [2011]
  • Consolidation radiotherapy in primary central nervous system lymphomas : impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy
    Ferreri AJ Int J Radiat Oncol Biol Phys 80 169-175 [2011]
  • Combined-modality therapy for primary central nervous system lymphoma : long-term data from a Phase II multicenter study(Trans-Tasman Radiation Oncology Group)
    O'Brien PC Int J Radiat Oncol Biol Phys 64 : 408 ~ 413 [2006]
  • Combined-modality therapy for primary central nervous system lymphoma : long-term data from a Phase II multicenter study(Trans-Tasman Radiation Oncology Group)
    O'Brien PC Int J Radiat Oncol Biol Phys 64 408-413 [2006]
  • Combined immunochemotherapy with reduced wholebrain radiotherapy for newly diagnosed primary CNS lymphoma
    Shah GD J Clin Oncol 25 : 4730 ~ 4735 [2007]
  • Combined immunochemotherapy with reduced wholebrain radiotherapy for newly diagnosed primary CNS lymphoma
    Shah GD J Clin Oncol 25 4730-4735 [2007]
  • Cognitive status and quality of life after treatment for primary CNS lymphoma
    Harder H Neurology 62 : 544 ~ 547 [2004]
  • Cognitive status and quality of life after treatment for primary CNS lymphoma
    Harder H Neurology 62 544-547 [2004]
  • Cognitive functions in primary CNS lymphoma after single or combined modality regimens
    Correa DD Neuro Oncol 14 : 101 ~ 108 [2012]
  • Cognitive functions in primary CNS lymphoma after single or combined modality regimens
    Correa DD Neuro Oncol 14 101-108 [2012]
  • Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years : a multicenter phase II study(26952)of the European Organization for Research and Treatment of Cancer Brain Tumor Group
    Hoang-Xuan K J Clin Oncol 21 : 2726 ~ 2731 [2003]
  • Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years : a multicenter phase II study(26952)of the European Organization for Research and Treatment of Cancer Brain Tumor Group
    Hoang-Xuan K J Clin Oncol 21 2726-2731 [2003]
  • CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
    Trotti A Semin Radiat Oncol 13 : 176 ~ 181 [2003]
  • CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
    Trotti A Semin Radiat Oncol 13 176-181 [2003]